Zimbabwe has turned down a significant American health deal valued at 367 million US dollars (£272m) over five years over Washington's request for confidential information.
This move was revealed after a official document from December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".
An official representative has since stated that the US was requesting genetic material for scientific study and commercial gain but was not willing to share the resulting advantages from any future vaccines.
"We are forced to start the difficult and regrettable task of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had furnished over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for continued negotiations to secure a agreement acceptable to both sides so the nation's vital HIV treatment initiative can continue.
Broader Implications
This development follows a comparable case in neighbouring Kenya, where a court halted a related health funding agreement following legal challenges were raised about the security of citizens' health data.
After returning to the presidency last year, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered aid for the US government, but Trump argued its spending was "inefficient" and his administration was pursuing direct bilateral agreements to enhance transparency and responsibility.
As per statements, Sixteen African countries have to date signed these new health pacts, representing over $18.3bn in committed funds.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration might have yielded extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million currently on HIV treatment through US-supported initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, with no corresponding guarantee of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"In essence, our country would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be available to our people if a future disease outbreak emerge."
National Interest and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting structures previously established through the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to deal with potential global health emergencies.
"This system is intended to guarantee that when a country contributes its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to develop them."
These objections over the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We encourage continued dialogue with our American counterparts on how future co-operation might be designed in a way that respects the sovereignty and interests of each country."
Health Experts Reaction
A leading public health body expressed it acknowledged the government's concerns, but suggested that talks must proceed considering a large portion of the nation's Aids initiatives relied on foreign aid.
"If technical issues exist, such as those relating to data governance or agreement terms, these can frequently be resolved via detailed discussion and negotiated safeguards," the group said.
The situation highlights the complex challenges between accepting crucial international aid and protecting a country's data in an increasingly data-driven world.